Ya Miao

Dr. Ya Miao

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PDF file
YZYuan Zhong
Yuan Zhong
XZXueli Zheng
Xueli Zheng
YMYa Miao
Ya Miao
HYHong Yan
Hong Yan
BWBeiyun Wang
Beiyun Wang
LWLili Wan
Lili Wan

1 January 2022 in Aging and disease
Verified
Journal Article
Open access
PDF file
LCLi-Zhen Cheng
Li-Zhen Cheng
WLWei Li
Wei Li
YCYi-Xin Chen
Yi-Xin Chen
YLYi-Jia Lin
Yi-Jia Lin
YMYa Miao
Ya Miao
Diabetic Encephalopathy (DE) is one of the complications of diabetes mellitus (DM) in the central nervous system. Up to now, the mechanisms of DE are not fully discussed by the field. Autophagy is an intracellular degradation pathway crucial to maintain cellular homeostasis by clearing damaged organelles, pathogens, and unwanted protein aggregates. Increasing evidence has demonstrated that autophagy might play an essential role in DE progress. In this review, we summarize the current evidence on autophagy dysfunction under the condition of DE, and provide novel insights of possibly biological mechanisms linking autophagy impairment to DE, as well as discuss autophagy-targeted therapies as potential treatments for DE

15 October 2018 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
YZYuan Zhong
Yuan Zhong
YZYitong Zhu
Yitong Zhu
THTing He
Ting He
WLWei Li
Wei Li
QLQinjie Li
Qinjie Li
YMYa Miao
Ya Miao
It is not known whether brain‑derived neurotrophic factor (BDNF) protects hippocampal neurons from high glucose‑induced apoptosis and/or synaptic plasticity dysfunction. The present study aimed to assess whether BDNF exerted a neuroprotective effect in rat hippocampal neurons exposed to high glucose and examine the underlying mechanisms. The apoptosis of primary hippocampal neurons was assessed by Annexin V‑fluorescein isothiocyanate/propidium iodide staining. The mRNA and protein expression levels were measured by reverse transcription‑­quantitative polymerase chain reaction and western blot experiments, respectively. Synaptic plasticity was evaluated by the immunolocalization of synaptophysin (Syn). Exposure of the hippocampal neurons to high glucose (75 mM for 72 h) resulted in cell apoptosis, decreased mRNA and protein expression levels of three synaptic plasticity‑related proteins (Syn, Arc and cyclic AMP response element‑binding protein), and changes in the cellular distribution of Syn, indicating loss of synaptic density. These effects of high glucose were partially or completely reversed by prior administration of BDNF (50 ng/ml for 24 h). Pre‑treatment with wortmannin, a phosphatidylinositol‑3‑kinase (PI3K) inhibitor, suppressed the ability of BDNF to inhibit the effects of high glucose. In addition, BDNF significantly upregulated the tropomyosin‑related kinase B, its cognate receptor, Akt and phosphorylated Akt at the protein levels under high glucose conditions. In conclusion, high glucose induced apoptosis and downregulated synaptic plasticity‑related proteins in hippocampal neurons. These effects were reversed by BDNF via the PI3K/Akt signaling pathway.

1 January 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
YZYuan Zhong
Yuan Zhong
YZYitong Zhu
Yitong Zhu
THTing He
Ting He
WLWei Li
Wei Li
HYHong Yan
Hong Yan
YMYa Miao
Ya Miao

23 May 2015 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YMYa Miao
Ya Miao
THTing He
Ting He
YZYitong Zhu
Yitong Zhu
WLWei Li
Wei Li
BWBeiyuan Wang
Beiyuan Wang
YZYuan Zhong
Yuan Zhong

4 May 2023 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
LCLizhen Cheng
Lizhen Cheng
YCYixin Chen
Yixin Chen
DGDonghao Guo
Donghao Guo
YZYuan Zhong
Yuan Zhong
WLWei Li
Wei Li
YMYa Miao
Ya Miao
Background: Diabetic encephalopathy (DE) is a complication of type 2 diabetes mellitus (T2DM) that features Alzheimer's disease (AD)-like pathology, which can be degraded by the autophagy-lysosome pathway (ALP). Since transcription factor EB (TFEB) is a master regulator of ALP, TFEB-mediated ALP activation might have a therapeutic effect on DE, but this has yet to be investigated. Methods: We established T2DM mouse models and cultured HT22 cells under high-glucose (HG) conditions to confirm the role of ALP in DE. To further investigate this, both mice and HT22 cells were treated with 3-methyladenine (3-MA). We also analyzed the content of TFEB in the nucleus and cytoplasm to evaluate its role in ALP. To confirm the effect of TFEB activation at the post-translational level in DE, we used rapamycin to inhibit the mechanistic target of rapamycin (mTOR). We transduced both mice and cells with TFEB vector to evaluate the therapeutic effect of TFEB overexpression on DE. Conversely, we conducted TFEB knockdown to verify its role in DE in another direction. Results: We found that T2DM mice experienced compromised cognitive function, while HG-cultured HT22 cells exhibited increased cell apoptosis. Additionally, both T2DM mice and HG-cultured HT22 cells showed impaired ALP and heavier AD-like pathology. This pathology worsened after treatment with 3-MA. We also observed decreased TFEB nuclear translocation in both T2DM mice and HG-cultured HT22 cells. However, inhibiting mTOR with rapamycin or overexpressing TFEB increased TFEB nuclear translocation, enhancing the clearance of ALP-targeted AD-like pathology. This contributed to protection against neuronal apoptosis and alleviation of cognitive impairment. Conversely, TFEB knockdown lessened ALP-targeted AD-like pathology clearance and had a negative impact on DE. Conclusion: Our findings suggest that impaired ALP is responsible for the aggravation of AD-like pathology in T2DM. We propose that mTOR-dependent TFEB activation and TFEB overexpression are promising therapeutic strategies for DE, as they enhance the clearance of ALP-targeted AD-like pathology and alleviate neuronal apoptosis. Our study provides insight into the underlying mechanisms of DE and offers potential avenues for the development of new treatments for this debilitating complication of T2DM. Graphic